Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003555889 | SCV004294363 | pathogenic | not provided | 2023-03-02 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1705). This premature translational stop signal has been observed in individual(s) with clinical features of Cockayne syndrome (PMID: 10196384). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Thr659Cysfs*24) in the ERCC6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ERCC6 are known to be pathogenic (PMID: 18628313, 29572252). |
Fulgent Genetics, |
RCV005041967 | SCV005675118 | pathogenic | DE SANCTIS-CACCHIONE SYNDROME; Cerebrooculofacioskeletal syndrome 1; Cockayne syndrome type 2; UV-sensitive syndrome 1; Age related macular degeneration 5; Premature ovarian failure 11; Lung cancer | 2024-06-18 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000001774 | SCV000021930 | pathogenic | Cockayne syndrome type 2 | 1999-05-01 | no assertion criteria provided | literature only |